Burning Rock Reports Fourth Quarter and Full Year 2021 Financial Results
GUANGZHOU, China, March 21, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
News
Ocugen, Inc. Appoints Jessica Crespo, CPA, to Chief Accounting Officer and Senior Vice President, Finance
MALVERN, Pa., March 21, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical company…
Solodev Launches Serverless Health Cloud to Power Fast, Secure, and Scalable Patient Portals on AWS
Announced during HIMSS 2022, Solodev now offers a serverless solution for enterprise-grade healthcare organizations to…
KKR Real Estate Finance Trust Inc. Tax Treatment of 2021 Series A Preferred Stock Dividends
NEW YORK–(BUSINESS WIRE)–KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) today announced the tax…
Humana Prices $750 Million Debt Offering
LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a…
TSA Group Chooses Alvaria Workforce Engagement Management For Volume Forecasting, Mobile Schedule Management and Optimal Seat Utilisation
MELBOURNE, Australia–(BUSINESS WIRE)–#ReshapingCX–Alvaria and Call Design announce a new Alvaria Workforce customer, TSA Group. Australia’s…
KBRA Assigns Preliminary Ratings to J.P. Morgan Mortgage Trust 2022-INV3 (JPMMT 2022-INV3)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 24 classes of mortgage pass-through certificates from J.P….
Orphazyme A/S has filed for voluntary delisting of ADSs
Orphazyme A/SCompany announcementNo. 12/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 21, 2022 – Orphazyme A/S…
SeqLL Announces Formation of Scientific Advisory Board
BILLERICA, Mass., March 21, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…
Statera Biopharma Announces Proposed Underwritten Public Offering
FORT COLLINS, Colo., March 21, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
AnaptysBio Appoints Daniel Faga As Interim Chief Executive Officer
Company to undergo a strategic portfolio review while continuing to execute on the development of…
Viridian Therapeutics Doses First Subject in First-in-Human Clinical Trial Evaluating VRDN-002, a Next Generation IGF-1R Antibody for the Treatment of Thyroid Eye Disease
– VRDN-002 incorporates clinically validated half-life extension technology to support development as a low volume…
DICE Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
On track to deliver topline proof-of-concept data from Phase 1 clinical trial of oral IL-17…
Terns Reports Top-line Results from Phase 1 AVIATION Trial of VAP-1 Inhibitor TERN-201
FOSTER CITY, Calif., March 21, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
TELA Bio Reports Fourth Quarter and Full Year 2021 Financial Results
MALVERN, Pa., March 21, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a…
Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (epinephrine) Injection for Potential Manufacturing Defect
SYMJEPI Photo 1 SYMJEPI SYMJEPI Photo 2 SYMJEPI SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE)…
AGTC Announces Proposed Public Offering of Common Stock
GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
Announces decision to discontinue development of ORIC-101 Company will focus on advancing its three single…
Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer
Philip Perera, M.D., to retire while continuing to participate as an advisor to Longboard Randall…
Voquent is Reinventing Voice-Over
Voquent is Reinventing Voice-Over Voquent is Reinventing Voice-Over 71-75 Shelton Street, London, WC2H 9JQ, United…